Letter to the Editor Regarding: Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study

Схожие документы

• Letter to the Editor Regarding: Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
  по: Ruiyao Hu, и др.
  Опубликовано: (2024-04-01)
• Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
  по: A. David Burden, и др.
  Опубликовано: (2023-09-01)
• Intralesional Spesolimab: A Novel and Effective Approach for Palmoplantar Pustulosis Treatment – A Case Report
  по: Wang SN, и др.
  Опубликовано: (2025-01-01)
• IL-36 Receptor Antagonist Spesolimab for Generalized Pustular Psoriasis Combined with Palmoplantar Pustulosis: A Case Report
  по: Tan H, и др.
  Опубликовано: (2026-04-01)
• Pustulosis palmoplantar
  по: Francisco Javier Zufía García, и др.
  Опубликовано: (2019)